Mental health Compass Pathways Soars: Analysts Eye 223% Upside After Historic Psilocybin Breakthrough March 08, 2026
Mental health Psilocybin Therapy Reaches Final Stage: FDA Review Could Deliver Breakthrough in 2026 March 07, 2026
Mental health COMP360 Psilocybin Breakthrough: Phase 3 Success Paves Way for FDA Approval March 07, 2026
Mental health New Study Links Frequent Bubble Tea Consumption to Higher Risks of Depression and Anxiety March 02, 2026
Mental health New Research: Frequent Bubble Tea Consumption Linked to Anxiety & Depression March 01, 2026
Mental health FDA Approves Revolutionary XCSITE 'Brainwave-Tuning' Device for Depression March 01, 2026
Mental health Breaking: FDA Clears Revolutionary XCSITE 'Brain-Tuning' Wearable for Rapid Depression Relief February 28, 2026
Mental health Breaking: Cannabis Use Linked to Doubling of Anxiety and Depression Rates in Landmark Study February 27, 2026
Mental health FDA Fast-Tracks 'Game-Changing' Psychedelic Treatment for Postpartum Depression February 25, 2026
